Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Saiz,LC"'
Autor:
Leache,L, Celaya,MC, Alzueta,N, Echeverría,A, Saiz,LC, Erviti,J, Garjón,J, Fontela,C, Sanz,L, Acín,MT, Fernández,ML, Gómez,N, Gutiérrez-Valencia,M, Calvo,DM
Publikováno v:
Revista de la OFIL v.31 n.4 2021
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SUMMARY Objective: Acute kidney injury (AKI) is a life-threatening condition characterized by an abrupt deterioration in kidney function. The simultaneous use of diuretics, renin-angiotensin-aldosterone system inhibitors, and non-steroidal anti-infla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::5eb3582ff086c47107779552d365c8f8
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1699-714X2021000400015
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1699-714X2021000400015
Publikováno v:
Revista de la OFIL v.30 n.3 2020
SciELO España: Revistas Científicas Españolas de Ciencias de la Salud
Instituto de Salud Carlos III (ISCIII)
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España: Revistas Científicas Españolas de Ciencias de la Salud
Instituto de Salud Carlos III (ISCIII)
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Resumen La pandemia por COVID-19 ha generado una crisis a todos los niveles, desde el sanitario hasta el económico, laboral y social. Los sistemas sanitarios han mostrado una enorme capacidad de adaptación a las necesidades, que han requerido de r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::00c635df6d90fe0ae80d2587cbe253ff
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1699-714X2020000300185
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1699-714X2020000300185
Autor:
Quirland, C, Solà, I, Leache, L, Saiz, LC, Gutiérrez-Valencia, M, Álamo-Junquera, D, Rubio-Valera, M, Aznar, I, Requeijo-Lorenzo, C, Santero, M, Savall, O, Breton, I, de Miguel-Díez, J, Bonfill, X
Publikováno v:
In Value in Health December 2022 25(12) Supplement:S282-S282
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Roncal-Belzunce V; Public University of Navarre (UPNA), Pamplona, Navarre, Spain; Navarre Institute for Health Research (IdiSNA), Pamplona, Navarre, Spain. Electronic address: victoria.roncal.belzunce@gmail.com., Gutiérrez-Valencia M; Navarre Institute for Health Research (IdiSNA), Pamplona, Navarre, Spain; Unit of Innovation and Organization, Navarre Health Service, Pamplona, Navarre, Spain. Electronic address: marta.gutierrez.valencia@navarra.es., Leache L; Navarre Institute for Health Research (IdiSNA), Pamplona, Navarre, Spain; Unit of Innovation and Organization, Navarre Health Service, Pamplona, Navarre, Spain. Electronic address: leire.leache.alegria@navarra.es., Saiz LC; Navarre Institute for Health Research (IdiSNA), Pamplona, Navarre, Spain; Unit of Innovation and Organization, Navarre Health Service, Pamplona, Navarre, Spain. Electronic address: lc.saiz.fernandez@navarra.es., Bell JS; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia. Electronic address: simon.bell2@monash.edu., Erviti J; Navarre Institute for Health Research (IdiSNA), Pamplona, Navarre, Spain; Unit of Innovation and Organization, Navarre Health Service, Pamplona, Navarre, Spain. Electronic address: juan.erviti.lopez@navarra.es., Martínez-Velilla N; Public University of Navarre (UPNA), Pamplona, Navarre, Spain; Navarre Institute for Health Research (IdiSNA), Pamplona, Navarre, Spain; Hospital Universitario de Navarra (HUN)- Navarrabiomed, Pamplona, Navarre, Spain. Electronic address: nicolas.martinez.velilla@navarra.es.
Publikováno v:
Ageing research reviews [Ageing Res Rev] 2024 Jul; Vol. 98, pp. 102317. Date of Electronic Publication: 2024 Apr 29.
Autor:
Leache L; Unit of Innovation and Organization, Navarre Health Service, Pamplona, Tudela 20, 1st floor, 31003, Spain., Gutiérrez Valencia M; Unit of Innovation and Organization, Navarre Health Service, Pamplona, Tudela 20, 1st floor, 31003, Spain., Saiz LC; Unit of Innovation and Organization, Navarre Health Service, Pamplona, Tudela 20, 1st floor, 31003, Spain., Erviti J; Unit of Innovation and Organization, Navarre Health Service, Pamplona, Tudela 20, 1st floor, 31003, Spain., Rojas Reyes MX; Institut d'Recerca-Servei d'Epidemiologia Clínica i Salut Pública, Hospital de la Santa Creu i Sant Pau, Barcelona, Carrer de Sant Quintí, 08041, Spain.
Publikováno v:
Open research Europe [Open Res Eur] 2024 May 21; Vol. 2, pp. 38. Date of Electronic Publication: 2024 May 21 (Print Publication: 2022).
Autor:
Riefolo F; Teamit Institute, Partnerships, Barcelona Health Hub, Barcelona, Spain; VAccine Monitoring Collaboration for Europe, Brussels, Belgium., Castillo-Cano B; Spanish Agency of Medicines and Medical Devices-AEMPS, Madrid, Spain., Martín-Pérez M; Spanish Agency of Medicines and Medical Devices-AEMPS, Madrid, Spain., Messina D; Agenzia Regionale di Sanita' Toscana, Florence, Italy., Elbers R; Department of Data Science and Biostatistics, University Medical Center Utrecht, the Netherlands., Brink-Kwakkel D; Department of Data Science and Biostatistics, University Medical Center Utrecht, the Netherlands., Villalobos F; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain., Ingrasciotta Y; Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Garcia-Poza P; Spanish Agency of Medicines and Medical Devices-AEMPS, Madrid, Spain., Swart-Polinder K; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands., Souverein P; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands., Saiz LC; Unit of Innovation and Organization, Navarre Health Service, Pamplona, Spain., Bissacco CA; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain., Leache L; Unit of Innovation and Organization, Navarre Health Service, Pamplona, Spain., Tari M; Caserta Local Health Unit, Caserta, Italy., Crisafulli S; Department of Medicine, University of Verona, Verona, Italy., Grimaldi L; l'Assistance Publique-Hôpitaux de Paris (APHP), University Paris-Saclay, Paris, France., Vaz T; Department of Data Science and Biostatistics, University Medical Center Utrecht, the Netherlands., Gini R; VAccine Monitoring Collaboration for Europe, Brussels, Belgium; Agenzia Regionale di Sanita' Toscana, Florence, Italy., Klungel O; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands., Martín-Merino E; VAccine Monitoring Collaboration for Europe, Brussels, Belgium; Spanish Agency of Medicines and Medical Devices-AEMPS, Madrid, Spain. Electronic address: emartinm@aemps.es.
Publikováno v:
Vaccine [Vaccine] 2023 Nov 13; Vol. 41 (47), pp. 7007-7018. Date of Electronic Publication: 2023 Oct 17.
Autor:
Maestro C; Autonomous University of Barcelona (UAB), Barcelona, Spain., Leache L; Unit of Innovation and Organization, Navarre Health Service, Tudela Street 20, first floor, 31003, Pamplona, Navarre, Spain. lleachea@navarra.es.; Navarre Institute for Health Research (IdiSNA), Pamplona, Navarre, Spain. lleachea@navarra.es., Gutiérrez-Valencia M; Unit of Innovation and Organization, Navarre Health Service, Tudela Street 20, first floor, 31003, Pamplona, Navarre, Spain.; Navarre Institute for Health Research (IdiSNA), Pamplona, Navarre, Spain., Saiz LC; Unit of Innovation and Organization, Navarre Health Service, Tudela Street 20, first floor, 31003, Pamplona, Navarre, Spain.; Navarre Institute for Health Research (IdiSNA), Pamplona, Navarre, Spain., Gómez H; Radiology Service, University Hospital of Navarre, Navarre Health Service, Pamplona, Navarre, Spain., Bacaicoa MC; Radiology Service, University Hospital of Navarre, Navarre Health Service, Pamplona, Navarre, Spain., Erviti J; Unit of Innovation and Organization, Navarre Health Service, Tudela Street 20, first floor, 31003, Pamplona, Navarre, Spain.; Navarre Institute for Health Research (IdiSNA), Pamplona, Navarre, Spain.
Publikováno v:
European radiology [Eur Radiol] 2023 Sep; Vol. 33 (9), pp. 6569-6581. Date of Electronic Publication: 2023 Apr 18.
Autor:
Gutiérrez-Valencia M; Unit of Innovation and Organization, Navarre Health Service.; Navarre Institute for Health Research (IdiSNA)., Leache L; Unit of Innovation and Organization, Navarre Health Service.; Navarre Institute for Health Research (IdiSNA)., Saiz LC; Unit of Innovation and Organization, Navarre Health Service.; Navarre Institute for Health Research (IdiSNA)., Beloqui JJ; Navarre Institute for Health Research (IdiSNA).; Pharmacy Service, Navarra University Hospital, Navarre Health Service.; Genomic Medicine Unit, Navarrabiomed., Barajas M; Biochemistry Area, Department of Health Science, Public University of Navarre., Vicuña M; Inflammatory Bowel Disease Unit, Gastroenterology Department, Navarra University Hospital, Navarre Health Service, Pamplona, Navarre, Spain., Erviti J; Unit of Innovation and Organization, Navarre Health Service.; Navarre Institute for Health Research (IdiSNA).
Publikováno v:
Journal of clinical gastroenterology [J Clin Gastroenterol] 2023 Aug 01; Vol. 57 (7), pp. 671-685. Date of Electronic Publication: 2023 Aug 01.
Autor:
Calvo DM; Autonomous University of Barcelona (UAB), Barcelona, Spain., Saiz LC; Unit of Innovation and Organization, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Leache L; Unit of Innovation and Organization, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Celaya MC; Subdirectorate of Pharmacy and Health Benefits, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Gutiérrez-Valencia M; Unit of Innovation and Organization, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Alonso A; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA., Erviti J; Unit of Innovation and Organization, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Alzueta N; Subdirectorate of Pharmacy and Health Benefits, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Echeverría A; Subdirectorate of Pharmacy and Health Benefits, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Garjón J; Subdirectorate of Pharmacy and Health Benefits, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Fontela C; Pharmacy Service, Donostia University Hospital, OSI Donostialdea, Osakidetza, San Sebastián, Spain., Sanz L; Subdirectorate of Pharmacy and Health Benefits, Navarre Health Service, Pamplona, Spain., Acín MT; Subdirectorate of Pharmacy and Health Benefits, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Fernández ML; Nephrology Service, Navarre University Hospital, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain., Gómez N; Nephrology Service, Navarre University Hospital, Navarre Health Service, Navarra Health Research Institute (IdiSNA), Pamplona, Spain.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2023 Aug; Vol. 32 (8), pp. 898-909. Date of Electronic Publication: 2023 Apr 05.